Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.
This 2021 review looks at plant-derived cannabinoids as possible treatments for epilepsy. It focuses on four compounds — CBD, CBDV, Δ9-THCV and CBG — and reviews what is known about how they might work in the brain and what animal and human studies have shown. The authors say there is…
This review looked at 47 completed clinical trials of cannabinoids (mainly THC and CBD) for brain and nerve conditions. Some trials showed benefits for symptoms like spasticity in multiple sclerosis and for certain forms of epilepsy, but results for pain were mixed. The authors say the evidence is promising but…
